| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 33,6 M € | -37.1% | 53,5 M € | -7.1% | 57,6 M € | +7.8% | 53,4 M € | +6.3% | 50,2 M € | +3.4% | 48,6 M € | +2.6% | 47,4 M € | +5.5% | 44,9 M € | +2.4% | 43,8 M € | +1.9% | 43,0 M € | +2.8% | 41,8 M € | -4.8% | 43,9 M € | +5.3% | 41,7 M € | -1.0% | 42,1 M € | +4.8% | 40,2 M € | +1.7% | 39,5 M € | +5.5% | 37,5 M € | +8.1% | 34,7 M € | |
| EBITDA | 7,7 M € | -76.5% | 32,6 M € | +128.0% | 14,3 M € | +1.6% | 14,1 M € | -1.2% | 14,2 M € | +8.1% | 13,2 M € | +0.7% | 13,1 M € | +1.1% | 12,9 M € | +13.1% | 11,4 M € | -7.8% | 12,4 M € | +23.1% | 10,1 M € | -1.3% | 10,2 M € | +41.9% | 7,2 M € | -2.4% | 7,4 M € | -6.5% | 7,9 M € | +7.5% | 7,3 M € | +35.6% | 5,4 M € | +11.7% | 4,8 M € | |
| Operating profit | 6,1 M € | -79.9% | 30,2 M € | +166.1% | 11,3 M € | +2.9% | 11,0 M € | +1.9% | 10,8 M € | +10.5% | 9,8 M € | +0.4% | 9,8 M € | -2.4% | 10,0 M € | +17.1% | 8,5 M € | -3.4% | 8,8 M € | +41.9% | 6,2 M € | -0.8% | 6,3 M € | +117.7% | 2,9 M € | -32.3% | 4,3 M € | -20.8% | 5,4 M € | +8.1% | 5,0 M € | +70.2% | 2,9 M € | +5.0% | 2,8 M € | |
| Profit/loss | 4,6 M € | -79.6% | 22,4 M € | +171.5% | 8,2 M € | +1.9% | 8,1 M € | +1.4% | 8,0 M € | -1.6% | 8,1 M € | +30.3% | 6,2 M € | -10.5% | 7,0 M € | +22.6% | 5,7 M € | -3.2% | 5,9 M € | +52.0% | 3,9 M € | -8.5% | 4,2 M € | +210.0% | 1,4 M € | -46.4% | 2,5 M € | -30.2% | 3,6 M € | +13.9% | 3,2 M € | +70.3% | 1,9 M € | -4.7% | 2,0 M € | |
| Equity | 18,6 M € | +32.0% | 14,1 M € | -27.7% | 19,4 M € | +24.6% | 15,6 M € | +3.9% | 15,0 M € | +3.3% | 14,5 M € | -5.8% | 15,4 M € | -4.8% | 16,2 M € | -15.8% | 19,2 M € | +10.2% | 17,5 M € | +50.5% | 11,6 M € | +49.8% | 7,7 M € | -18.8% | 9,5 M € | -5.7% | 10,1 M € | +33.5% | 7,6 M € | +8.2% | 7,0 M € | +10.2% | 6,4 M € | -3.4% | 6,6 M € | |
| Total assets | 27,2 M € | +12.2% | 24,2 M € | -41.8% | 41,6 M € | +16.2% | 35,8 M € | +0.1% | 35,8 M € | -0.5% | 35,9 M € | +6.6% | 33,7 M € | -9.3% | 37,2 M € | +0.8% | 36,9 M € | +20.5% | 30,6 M € | +4.2% | 29,4 M € | +14.3% | 25,7 M € | -6.9% | 27,6 M € | -9.4% | 30,5 M € | +42.0% | 21,5 M € | +7.0% | 20,1 M € | +5.5% | 19,0 M € | -2.8% | 19,6 M € | |
| Cash | 490,3 k € | +18272.6% | 2,7 k € | -85.9% | 19,0 k € | +43.4% | 13,2 k € | -95.3% | 281,0 k € | +7226.4% | 3,8 k € | +43.7% | 2,7 k € | +565.8% | 400,8 € | -78.0% | 1,8 k € | -11.6% | 2,1 k € | -49.1% | 4,1 k € | +39.3% | 2,9 k € | +21.7% | 2,4 k € | -97.2% | 86,3 k € | +185.7% | 30,2 k € | +208.2% | 9,8 k € | +36.4% | 7,2 k € | -84.0% | 45,0 k € | |
| Debts | 8,1 M € | -16.6% | 9,7 M € | -54.3% | 21,3 M € | +9.7% | 19,4 M € | -2.2% | 19,8 M € | -2.1% | 20,2 M € | +21.3% | 16,7 M € | -15.5% | 19,7 M € | +20.8% | 16,3 M € | +36.6% | 12,0 M € | -22.9% | 15,5 M € | +0.3% | 15,5 M € | -1.2% | 15,7 M € | -13.5% | 18,1 M € | +57.2% | 11,5 M € | +11.0% | 10,4 M € | -1.7% | 10,5 M € | -7.3% | 11,4 M € | |
| Staff | 33,8 | 117,2 | 130,6 | 125,6 | 124,6 | 124,3 | 127,5 | 127,6 | 124,8 | 122,4 | 122,7 | 128,8 | 128,5 | 134,7 | 139,1 | 139,2 | 140,1 | 139 | ||||||||||||||||||
Public limited company · Zaventem · incorporated on 24/02/1989 · 33,8 ETP
Public limited company profitable and well capitalised. Cash position rising (+18272.6%).
Solid counterparty for a standard engagement.
AIR LIQUIDE MEDICAL is a Public limited company incorporated in 1989. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Zaventem. It employs on average 33,8 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette